Skip to main content
. 2020 Nov 25;124(4):721–727. doi: 10.1038/s41416-020-01141-8

Table 3.

Treatment efficacy.

Arm A
(Chemo)
Arm B
(Chemo + Cet)
All patients
N = 72 N = 78 N = 150
Tumour response
PR 11 17 28
15% 22% 19%
95% CI: 7.9–26% 13–33% 13–26%
SD 25 25 50
PD 31 32 63
NA 5 4 9
Progression-free survival
Median 3.71 4.56 3.84
95% CI 3.04–4.37 2.89–6.22 2.90–4.77
HR 0.98 95% CI: 0.70–1.37
Overall survival
Median 8.13 7.38 8.13
95% CI 6.46–9.80 5.12–9.64 6.81–9.46
HR 1.10 95% CI: 0.77–1.56

Bold values indicate statistical significance.